These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3011676)

  • 1. Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate.
    Kotani S; Takada H; Takahashi I; Tsujimoto M; Ogawa T; Ikeda T; Harada K; Okamura H; Tamura T; Tanaka S
    Infect Immun; 1986 Jun; 52(3):872-84. PubMed ID: 3011676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Takahashi I; Ikeda T; Otsuka K; Shimauchi H; Kasai N; Mashimo J
    Infect Immun; 1985 Jul; 49(1):225-37. PubMed ID: 3891627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.
    Takahashi I; Kotani S; Takada H; Tsujimoto M; Ogawa T; Shiba T; Kusumoto S; Yamamoto M; Hasegawa A; Kiso M
    Infect Immun; 1987 Jan; 55(1):57-68. PubMed ID: 3539807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiological activities of synthetic lipid A analogs with low endotoxicity.
    Kotani S; Takada H; Takahashi I; Ogawa T; Tsujimoto M; Shimauchi H; Ikeda T; Okamura H; Tamura T; Harada K
    Infect Immun; 1986 Dec; 54(3):673-82. PubMed ID: 3781622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.
    Takada H; Kotani S; Tsujimoto M; Ogawa T; Takahashi I; Harada K; Katsukawa C; Tanaka S; Shiba T; Kusumoto S
    Infect Immun; 1985 Apr; 48(1):219-27. PubMed ID: 3980084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis.
    Ogawa T
    Eur J Biochem; 1994 Feb; 219(3):737-42. PubMed ID: 8112323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Salmonella-type lipid A antigen with high serological specificity.
    Kasai N; Arata S; Mashimo J; Okuda K; Aihara Y; Kotani S; Takada H; Shiba T; Kusumoto S; Imoto M
    Infect Immun; 1986 Jan; 51(1):43-8. PubMed ID: 3941004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
    Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
    Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506).
    Ogawa T; Suda Y; Kashihara W; Hayashi T; Shimoyama T; Kusumoto S; Tamura T
    Vaccine; 1997 Oct; 15(15):1598-605. PubMed ID: 9364689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate.
    Tanamoto K; Zähringer U; McKenzie GR; Galanos C; Rietschel ET; Lüderitz O; Kusumoto S; Shiba T
    Infect Immun; 1984 May; 44(2):421-6. PubMed ID: 6715042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.
    Lam C; Hildebrandt J; Schütze E; Rosenwirth B; Proctor RA; Liehl E; Stütz P
    Infect Immun; 1991 Jul; 59(7):2351-8. PubMed ID: 1646770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural heterogeneity regarding local Shwartzman activity of lipid A.
    Mashimo J; Tanaka C; Arata S; Akiyama Y; Hata S; Hirayama T; Egawa K; Kasai N
    Microbiol Immunol; 1988; 32(7):653-66. PubMed ID: 3057331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A.
    Galanos C; Lehmann V; Lüderitz O; Rietschel ET; Westphal O; Brade H; Brade L; Freudenberg MA; Hansen-Hagge T; Lüderitz T
    Eur J Biochem; 1984 Apr; 140(2):221-7. PubMed ID: 6714230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements of lipid A species in activation of clotting enzymes from the horseshoe crab, and the human complement cascade.
    Takada H; Kotani S; Tanaka S; Ogawa T; Takahashi I; Tsujimoto M; Komuro T; Shiba T; Kusumoto S; Kusunose N
    Eur J Biochem; 1988 Aug; 175(3):573-80. PubMed ID: 3044789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of synthetic heptaacyl lipid A representing a component of Salmonella minnesota R595 lipid A.
    Galanos C; Lüderitz O; Freudenberg M; Brade L; Schade U; Rietschel ET; Kusumoto S; Shiba T
    Eur J Biochem; 1986 Oct; 160(1):55-9. PubMed ID: 3490368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Harada K; Mori Y; Kawasaki A; Tanaka A; Nagao S; Tanaka S
    Infect Immun; 1984 Jul; 45(1):293-6. PubMed ID: 6735470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antigenic reactivity of synthetic lipid A analogues as determined by monoclonal and conventional antibodies.
    Kasai N; Arata S; Mashimo J; Okuda K; Aihara Y; Kotani S; Takada H; Shiba T; Kusumoto S
    Biochem Biophys Res Commun; 1985 Apr; 128(2):607-12. PubMed ID: 2581565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
    Mashimo J; Mizutani T; Mita A; Kasai N
    Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Mori Y; Sakuta M; Kawasaki A; Inage M; Kusumoto S; Shiba T; Kasai N
    Infect Immun; 1983 Aug; 41(2):758-73. PubMed ID: 6409812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activities of chemically synthesized 2-keto-3-deoxyoctonic acid-(alpha 2----6)-D-glucosamine analogs of lipid A.
    Shimizu T; Akiyama S; Masuzawa T; Yanagihara Y; Nakamoto S; Achiwa K
    Infect Immun; 1987 Sep; 55(9):2287-9. PubMed ID: 3623704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.